$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
What is the effective target of gefitinib? People targeted by lung cancer want to know about the speed points
2025-10-19 11:44:20
Check Details
Do I need to be tested before taking the targeted drug cabozantinib?
2025-10-19 11:44:20
Check Details
【Are you curious】What will happen to your skin after using Gitairinib (afatinib)
2025-10-19 11:44:20
Check Details
up to date! Xakori (Crizotinib) medical insurance reimbursement requirements. If you want to be reimbursed, please click here
2025-10-19 11:44:20
Check Details
How effective is gefitinib in the treatment of locally advanced or metastatic non-small cell lung cancer? See what the experts say
2025-10-19 11:44:20
Check Details
The latest medical insurance reimbursement conditions for the lung cancer targeted drug gefitinib are here, and lung cancer patients are overjoyed
2025-10-19 11:44:20
Check Details
How long does it take to develop drug resistance after taking Giterinib (afatinib)? Expert advice
2025-10-19 11:44:20
Check Details
Data on the efficacy of the targeted drug cabozantinib in the treatment of RET rearranged lung cancer
2025-10-19 11:44:20
Check Details
Increase the reimbursement ratio? The latest interpretation of Jitai Rui’s 2021 medical insurance reimbursement policy
2025-10-19 11:44:20
Check Details
Can Xekori (crizotinib capsules) be reimbursed by medical insurance? What is the latest reimbursement rate?
2025-10-19 11:44:20
Check Details
Analysis of the efficacy and adverse reactions of cabozantinib in the treatment of RET rearranged lung cancer
2025-10-19 11:44:20
Check Details
How much does a box of lung cancer targeted drug gefitinib cost? Where to buy and save money?
2025-10-19 11:44:20
Check Details
1
2
...
3901
3902
3903
3904
3905
3906
3907
...
4152
4153
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
2
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
3
A Revolutionary Targeted Therapy for Hematological Malignancies
4
A New Option for Advanced Renal Cell Carcinoma Treatment
5
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
6
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
7
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide
8
Fulvestrant (Faslodex) Breast Cancer Guide: Indications, Dosage and Safety Specifications
9
Adagrasib (Krazati): Full Guide to KRAS G12C Inhibitor for Cancer Treatment
10
Comprehensive Analysis of the Third-Generation EGFR-TKI
11
ATOMIC Study: Atezolizumab Plus Chemo Improves DFS in dMMR Stage III Colon Cancer
12
Oncology Immunotherapy vs Anti-Inflammatory Biologic: Dostarlimab vs Secukinumab - A Mechanism-Centered Comparison